Caris Life Sciences
39 followers -
Fulfilling the promise of personalized medicine.
Fulfilling the promise of personalized medicine.
39 followers
Caris Life Sciences's posts
Post has attachment
Public
More treatment options can mean more time with loved ones. Learn about MyCancer and precision medicine: http://bit.ly/2u02PJ3
Post has attachment
Public
Breaking news - Caris Life Sciences’ Molecular Intelligence Platform Identifies Patients with MSI-High (or Mismatch Repair Deficient) Solid Tumors More Likely to Respond to Immunotherapy. http://bit.ly/2s0VneG
Post has attachment
Public
Breaking news - Caris Life Sciences, National Cancer Institute and ECOG-ACRIN Collaborate to Molecularly Identify Candidates for the NCI-MATCH Clinical Trial. Read more: http://bit.ly/2s3YrHM
Post has attachment
Public
Visit us at the 2017 ASCO Annual Meeting & explore some of the world’s most advanced profiling technologies that drive our industry-leading molecular insights.
Post has attachment
Public
John Marshall, M.D., appointed Chief Medical Officer for #CarisLS – read more: http://bit.ly/2rdvwRd
Post has attachment
Public
Latest immunotherapy news - FDA Approves Pembrolizumab for Urothelial Carcinoma: http://bit.ly/2qWQWly via @OncLive
Post has attachment
Public
Take a look at the full schedule of Caris Life Sciences posters being presented at ASCO 2017 here: http://bit.ly/2rvSDU4
Post has attachment
Public
Caris Life Sciences is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine. View our research publications: http://bit.ly/2oI17II #WeAreCarisLS
Public
A MSI dataset of 17,500+ strong, across all solid tumors – we call that Molecular Intelligence. #WorldLeaderImmunotherapyDx #CarisMI
Post has attachment
Public
The Caris COE Network Executive Committee facilitates collaborative research studies and coordinates outcome tracking initiatives. Meet the members: http://bit.ly/2ofxiLO
Wait while more posts are being loaded